Close

UPDATE: H.C. Wainwright Downgrades Intercept Pharmaceuticals (ICPT) to Sell

February 23, 2021 6:47 AM EST Send to a Friend
(Updated - February 23, 2021 7:01 AM EST)

H.C. Wainwright analyst Ed Arce downgraded Intercept Pharmaceuticals (NASDAQ: ICPT) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login